we have conducted a phase ii trial of cisdiammino-dichloro platinum ( cddp ) which demonstrates its remarkable activity in testis embryonic carcinoma , in ovary carcinoma and in epidermoid cancers , especially head and neck and uterus cervix carcinoma .
C0006826
cancers
C0302592
uterus cervix